These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 17508532

  • 1. Management of hypertriglyceridemia.
    Oh RC, Lanier JB.
    Am Fam Physician; 2007 May 01; 75(9):1365-71. PubMed ID: 17508532
    [Abstract] [Full Text] [Related]

  • 2. Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia.
    Wohl DA, Tien HC, Busby M, Cunningham C, Macintosh B, Napravnik S, Danan E, Donovan K, Hossenipour M, Simpson RJ.
    Clin Infect Dis; 2005 Nov 15; 41(10):1498-504. PubMed ID: 16231263
    [Abstract] [Full Text] [Related]

  • 3. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ, Yellon DM.
    Heart; 2008 Jun 15; 94(6):706-14. PubMed ID: 18480348
    [Abstract] [Full Text] [Related]

  • 4. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M, Sazonov V, Gutkin SW, Hokanson JE.
    J Cardiovasc Pharmacol; 2008 Apr 15; 51(4):331-51. PubMed ID: 18427276
    [Abstract] [Full Text] [Related]

  • 5. Hypertriglyceridemia: management of atherogenic dyslipidemia.
    Bersot T, Haffner S, Harris WS, Kellick KA, Morris CM.
    J Fam Pract; 2006 Jul 15; 55(7):S1-8. PubMed ID: 16822443
    [Abstract] [Full Text] [Related]

  • 6. Utility of currently available modes of therapy in reaching lipid goals.
    Spratt KA, Denke MA.
    J Am Osteopath Assoc; 2004 Sep 15; 104(9 Suppl 7):S14-6. PubMed ID: 15467019
    [Abstract] [Full Text] [Related]

  • 7. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
    Fazio S.
    Clin Ther; 2008 Feb 15; 30(2):294-306. PubMed ID: 18343268
    [Abstract] [Full Text] [Related]

  • 8. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
    McKenney JM, Sica D.
    Pharmacotherapy; 2007 May 15; 27(5):715-28. PubMed ID: 17461707
    [Abstract] [Full Text] [Related]

  • 9. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
    Cardenas GA, Lavie CJ, Cardenas V, Milani RV, McCullough PA.
    Rev Cardiovasc Med; 2008 May 15; 9(4):239-58. PubMed ID: 19122582
    [Abstract] [Full Text] [Related]

  • 10. New approaches in the intensive management of cardiovascular risk in the metabolic syndrome.
    Rosenson RS.
    Curr Probl Cardiol; 2005 May 15; 30(5):241-79. PubMed ID: 15829899
    [Abstract] [Full Text] [Related]

  • 11. Effect of lipid-lowering drug therapy on small-dense low-density lipoprotein.
    Backes JM, Gibson CA.
    Ann Pharmacother; 2005 Mar 15; 39(3):523-6. PubMed ID: 15671087
    [Abstract] [Full Text] [Related]

  • 12. Is it necessary to add fibrate to statin therapy in the management of dyslipidemia of metabolic syndrome?
    Turhan H, Yetkin E.
    Int J Cardiol; 2006 Jun 16; 110(2):276-7. PubMed ID: 16364471
    [Abstract] [Full Text] [Related]

  • 13. First-line therapies for lowering triglyceride levels.
    Raghavan VA.
    Am Fam Physician; 2008 Feb 15; 77(4):416; author reply 417-8. PubMed ID: 18326158
    [No Abstract] [Full Text] [Related]

  • 14. High-density lipoprotein metabolism: potential therapeutic targets.
    Davidson MH, Toth PP.
    Am J Cardiol; 2007 Dec 03; 100(11 A):n32-40. PubMed ID: 18047851
    [Abstract] [Full Text] [Related]

  • 15. Treating hypertriglyceridemia.
    Röggla G, Fasan M, Kapiotis S.
    CMAJ; 2007 Sep 11; 177(6):603; author reply 604-5. PubMed ID: 17846444
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of high-risk older persons with lipid-lowering drug therapy.
    Aronow WS.
    Am J Ther; 2008 Sep 11; 15(2):102-7. PubMed ID: 18356628
    [Abstract] [Full Text] [Related]

  • 17. [Hypertriglyceridemia].
    Föger B, Patsch JR.
    Wien Med Wochenschr; 1994 Sep 11; 144(12-13):308-11. PubMed ID: 8650934
    [Abstract] [Full Text] [Related]

  • 18. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
    Staels B, Maes M, Zambon A.
    Nat Clin Pract Cardiovasc Med; 2008 Sep 11; 5(9):542-53. PubMed ID: 18628776
    [Abstract] [Full Text] [Related]

  • 19. A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome.
    Davidson M.
    Am J Cardiol; 2008 Dec 22; 102(12A):19L-27L. PubMed ID: 19084086
    [Abstract] [Full Text] [Related]

  • 20. Treating hypertriglyceridemia.
    Yavasoglu I, Kadikoylu G, Bolaman Z.
    CMAJ; 2007 Sep 11; 177(6):603-4; author reply 604-5. PubMed ID: 17846443
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.